Clik here to view.
Pfizer’s Opioid Embeda to Be Discontinued
The long and winding road for the drug Embeda® (morphine sulfate and naltrexone hydrochloride) appears to be nearing its end. The manufacturer, Pfizer, has not yet released any public information, but...
View ArticleClik here to view.
Latest MedWatch Safety Alert: Significant Concern for Workers’ Compensation
The U.S. Food and Drug Administration (FDA) recently released a MedWatch Safety Alert regarding serious concerns around the use of gabapentinoids and the risk of serious breathing problems for patients...
View ArticleClik here to view.
The Future of Pharmacy
When I graduated from pharmacy school over forty years ago I had a vision for a future of pharmacy where pharmacists were recognized and compensated for their knowledge of medication as opposed to the...
View ArticleAmerica’s State of Mind: Use of Mental Health Medications Increasing with...
New Express Scripts Research Examines Americans’ Use of Mental Health Medications While COVID-19 makes its monumental mark on the world’s health and economy, new research from Express Scripts reveals...
View ArticleClik here to view.
Our Commitment During COVID-19
A Message from myMatrixx President, Mike Cirillo myMatrixx works hard, every day, to be your trusted partner for better workers’ compensation PBM support. That means bringing innovative solutions to...
View ArticleTreating Opioid Use Disorder with Buprenorphine may Provide Dual Benefit for...
The opioid epidemic has become a national public health problem. Although, the opioid epidemic is being addressed nationally and drug overdose deaths decreased by 4% from 2017 to 2018, still more than...
View ArticleClik here to view.
myMatrixx and Tower Premiere Webinar: A Prescription for Settling Legacy Claims
As claims age, the percentage of spend for prescription drugs increases. Further, as claims age, the likelihood that the injured worker becomes a Medicare beneficiary as a result of age or disability...
View ArticleClik here to view.
Making Sense of Workers’ Comp Pharmaceuticals During COVID-19
When the COVID-19 pandemic became a serious concern all the way back in March, businesses had to find a way to adapt. Since it is abundantly clear that this is in no way a short-term problem, it is...
View ArticleClik here to view.
Three Drugs on the Horizon to Watch in Workers’ Comp Pharmacy
As we continue to move into 2021, two of the biggest concerns in workers’ compensation pharmaceuticals remain the ongoing COVID-19 pandemic and the opioid misuse crisis. In this environment, I believe...
View ArticleClik here to view.
How the myMatrixx E-Prescribing Program is Making a Difference
As part owner of Surescripts, myMatrixx, an Express Scripts company, is uniquely positioned to maximize the use of electronic prescribing, increasing efficiency, accuracy and patient safety for...
View Article
